- Home
- PRGO vs CLDX Comparison
PRGO vs CLDX Comparison
Compare PRGO & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRGO | CLDX |
|---|---|---|
| Founded | 1887 | N/A |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 2013 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PRGO | CLDX |
|---|---|---|
| Price | $14.15 | $30.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $20.33 | ★ $41.56 |
| AVG Volume (30 Days) | ★ 2.0M | 754.6K |
| Earning Date | 05-29-2026 | 05-28-2026 |
| Dividend Yield | ★ 8.05% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $800,000.00 | ★ $12,743,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $23.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $12.17 | $14.40 |
| 52 Week High | $30.93 | $31.00 |
Technical Indicators
Market Signals| Indicator | PRGO | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 44.20 | 70.32 |
| Support Level | $13.58 | $24.70 |
| Resistance Level | $14.82 | $30.50 |
| Average True Range (ATR) | 0.50 | 1.58 |
| MACD | -0.03 | 0.80 |
| Stochastic Oscillator | 63.78 | 90.03 |
Price Performance
Historical ComparisonAbout PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.